GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avid Bioservices Inc (NAS:CDMOP.PFD) » Definitions » Book Value per Share

CDMOP.PFD (Avid Bioservices) Book Value per Share : $0.00 (As of Oct. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Avid Bioservices Book Value per Share?

Avid Bioservices's book value per share for the quarter that ended in Oct. 2024 was $0.00.

During the past 12 months, Avid Bioservices's average Book Value Per Share Growth Rate was -75.90% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -9.00% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 15.60% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -1.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Avid Bioservices was 76.60% per year. The lowest was -65.70% per year. And the median was -2.95% per year.

Avid Bioservices's current price is $25.0602. Its book value per share for the quarter that ended in Oct. 2024 was $0.00. Hence, today's PB Ratio of Avid Bioservices is .

During the past 13 years, the highest P/B Ratio of Avid Bioservices was 42.14. The lowest was 1.37. And the median was 5.06.

Warning Sign:

Avid Bioservices Inc stock PB Ratio (=17.82) is close to 2-year high of 17.82.


Avid Bioservices Book Value per Share Historical Data

The historical data trend for Avid Bioservices's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avid Bioservices Book Value per Share Chart

Avid Bioservices Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Avid Bioservices Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Avid Bioservices's Book Value per Share

For the Biotechnology subindustry, Avid Bioservices's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avid Bioservices's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avid Bioservices's PB Ratio distribution charts can be found below:

* The bar in red indicates where Avid Bioservices's PB Ratio falls into.


;
;

Avid Bioservices Book Value per Share Calculation

Avid Bioservices's Book Value Per Share for the fiscal year that ended in Apr. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(60.89-0.00)/0.00
=N/A

Avid Bioservices's Book Value Per Share for the quarter that ended in Oct. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(44.81-0.00)/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Avid Bioservices  (NAS:CDMOP.PFD) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Avid Bioservices Book Value per Share Related Terms

Thank you for viewing the detailed overview of Avid Bioservices's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Avid Bioservices Business Description

Traded in Other Exchanges
N/A
Address
14191 Myford Road, Tustin, CA, USA, 92780
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.